The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance
- PMID: 18492770
- PMCID: PMC4043181
- DOI: 10.1152/ajpendo.00674.2007
The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance
Abstract
To assess the relationship between the fasting plasma glucose (FPG) concentration and insulin secretion in normal glucose tolerance (NGT) and impaired glucose tolerance (IGT) subjects, 531 nondiabetic subjects with NGT (n = 293) and IGT (n = 238; 310 Japanese and 232 Mexican Americans) received an oral glucose tolerance test (OGTT) with measurement of plasma glucose, insulin, and C-peptide every 30 min. The insulin secretion rate was determined by plasma C-peptide deconvolution. Insulin sensitivity (Matsuda index) was measured from plasma insulin and glucose concentrations. The insulin secretion/insulin resistance (IS/IR) or disposition index was calculated as DeltaISR/DeltaG / IR. As FPG increased in NGT subjects, the IS/IR index declined exponentially over the range of FPG from 70 to 125 mg/dl. The relationship between the IS/IR index and FPG was best fit with the equation: 28.8 exp(-0.036 FPG). For every 28 mg/dl increase in FPG, the IS/IR index declined by 63%. A similar relationship between IS/IR index and FPG was observed in IGT. However, the decay constant was lower than in NGT. The IS/IR index for early-phase insulin secretion (0-30 min) was correlated with the increase in FPG in both NGT and IGT (r = -0.43, P < 0.0001 and r = -0.20, P = 0.001, respectively). However, the correlation between late-phase insulin secretion (60-120 min) and FPG was not significant. In conclusion, small increments in FPG, within the "normal" range, are associated with a marked decline in glucose-stimulated insulin secretion and the decrease in insulin secretion with increasing FPG is greater in subjects with NGT than IGT and primarily is due to a decline in early-phase insulin secretion.
Figures



Similar articles
-
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.Acta Diabetol. 2011 Sep;48(3):209-17. doi: 10.1007/s00592-011-0285-x. Epub 2011 May 8. Acta Diabetol. 2011. PMID: 21553243 Clinical Trial.
-
Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.Diabetes Care. 1997 Oct;20(10):1562-8. doi: 10.2337/diacare.20.10.1562. Diabetes Care. 1997. PMID: 9314636
-
Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness.Diabetes Care. 1997 Mar;20(3):396-404. doi: 10.2337/diacare.20.3.396. Diabetes Care. 1997. PMID: 9051394
-
[Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].Zhonghua Nei Ke Za Zhi. 2004 Oct;43(10):735-9. Zhonghua Nei Ke Za Zhi. 2004. PMID: 15631823 Chinese.
-
Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.Hypertens Res. 2008 Jul;31(7):1357-63. doi: 10.1291/hypres.31.1357. Hypertens Res. 2008. PMID: 18957806
Cited by
-
A history of opioid exposure in females increases the risk of metabolic disorders in their future male offspring.Addict Biol. 2021 Jan;26(1):e12856. doi: 10.1111/adb.12856. Epub 2019 Nov 28. Addict Biol. 2021. PMID: 31782234 Free PMC article.
-
Plasma glucose concentration and prediction of future risk of type 2 diabetes.Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S194-8. doi: 10.2337/dc09-S309. Diabetes Care. 2009. PMID: 19875551 Free PMC article. Review. No abstract available.
-
Associations between maternal characteristics and pharmaceutical treatment of gestational diabetes: an analysis of the UK Born in Bradford (BiB) cohort study.BMJ Open. 2021 Nov 3;11(11):e053753. doi: 10.1136/bmjopen-2021-053753. BMJ Open. 2021. PMID: 34732497 Free PMC article.
-
Evaluation of the longitudinal deformation of the left ventricular myocardium in subjects with impaired fasting glucose with and without increased glycated hemoglobin.Anatol J Cardiol. 2018 Mar;19(3):160-167. doi: 10.14744/AnatolJCardiol.2017.7957. Epub 2018 Jan 24. Anatol J Cardiol. 2018. PMID: 29363665 Free PMC article.
-
Insulin Pulse Characteristics and Insulin Action in Non-diabetic Humans.J Clin Endocrinol Metab. 2021 May 13;106(6):1702-1709. doi: 10.1210/clinem/dgab100. J Clin Endocrinol Metab. 2021. PMID: 33606017 Free PMC article.
References
-
- DeFronzo RA. Lilly lecture 1987 RA. The triumvirate: beta-cell, muscle, liver.A collusion responsible for NIDDM. Diabetes 37: 667–687, 1988 - PubMed
-
- DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 8: 787–835, 2004 - PubMed
-
- Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest 32: 35–45, 2002 - PubMed
-
- Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46: 3–19, 2003 - PubMed
-
- Kahn SE. Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86: 4047–4058, 2001 - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials